Note eryone develops antibodies against SARS-Cov-2 when infected. It isn’t suprising since it is a common result when the same thing is investigated in other viral infections. Many factors are involved.
https://www.labroots.com/trending/coronavirus/21206/covid-19-patients-develop-antibodies